Net Cash Provided by (Used in) Operating Activities |
-17.4K |
USD |
+43.1% |
Q3 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
17.3K |
USD |
-43.2% |
Q3 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
FY 2024 |
Common Stock, Shares, Issued |
7.07M |
shares |
0% |
Q2 2024 |
FY 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
FY 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-13 |
USD |
|
Q3 2023 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
175K |
USD |
+9.03% |
Q2 2022 |
FY 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
175K |
USD |
+9.03% |
Q2 2022 |
FY 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
FY 2024 |
Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
FY 2024 |
Additional Paid in Capital |
107K |
USD |
0% |
Q2 2024 |
FY 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
FY 2024 |